Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The treatment is safe and shows promise for metastatic breast cancer.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

The tool accurately tracks eyebrow hair loss in chemotherapy patients.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.